Nan Shan Life Insurance Co. Ltd. Has $12.30 Million Stock Holdings in SPDR S&P Biotech ETF $XBI

Nan Shan Life Insurance Co. Ltd. decreased its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 43.9% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 77,701 shares of the exchange traded fund’s stock after selling 60,910 shares during the period. Nan Shan Life Insurance Co. Ltd. owned approximately 0.12% of SPDR S&P Biotech ETF worth $12,296,000 at the end of the most recent quarter.

A number of other institutional investors also recently modified their holdings of the business. Axiom Investment Management LLC acquired a new position in shares of SPDR S&P Biotech ETF during the 1st quarter worth approximately $26,000. Financial Life Planners bought a new stake in shares of SPDR S&P Biotech ETF in the first quarter valued at approximately $27,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC bought a new position in SPDR S&P Biotech ETF during the 4th quarter worth $27,000. Intesa Sanpaolo Wealth Management bought a new position in SPDR S&P Biotech ETF during the 4th quarter worth $30,000. Finally, SHP Wealth Management acquired a new position in SPDR S&P Biotech ETF in the 4th quarter valued at $31,000.

SPDR S&P Biotech ETF Stock Performance

NYSEARCA:XBI opened at $163.40 on Wednesday. The stock has a fifty day moving average price of $157.44 and a 200-day moving average price of $139.75. The company has a market cap of $10.67 billion, a price-to-earnings ratio of 11.47 and a beta of 0.83. SPDR S&P Biotech ETF has a fifty-two week low of $91.10 and a fifty-two week high of $169.89.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.